These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 11303953)

  • 21. Characterization of efflux transporters involved in distribution and disposition of apixaban.
    Zhang D; He K; Herbst JJ; Kolb J; Shou W; Wang L; Balimane PV; Han YH; Gan J; Frost CE; Humphreys WG
    Drug Metab Dispos; 2013 Apr; 41(4):827-35. PubMed ID: 23382458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saturable absorptive transport of the hydrophilic organic cation ranitidine in Caco-2 cells: role of pH-dependent organic cation uptake system and P-glycoprotein.
    Bourdet DL; Thakker DR
    Pharm Res; 2006 Jun; 23(6):1165-77. PubMed ID: 16741655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bidirectional transport of rhodamine 123 and Hoechst 33342, fluorescence probes of the binding sites on P-glycoprotein, across MDCK-MDR1 cell monolayers.
    Tang F; Ouyang H; Yang JZ; Borchardt RT
    J Pharm Sci; 2004 May; 93(5):1185-94. PubMed ID: 15067695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay.
    Balimane PV; Chong S
    Int J Pharm; 2005 Sep; 301(1-2):80-8. PubMed ID: 16023314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X; Whitfield LR; Stewart BH
    Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation and application of Caco-2 assays for the in vitro evaluation of development candidate drugs as substrates or inhibitors of P-glycoprotein to support regulatory submissions.
    Elsby R; Surry DD; Smith VN; Gray AJ
    Xenobiotica; 2008 Jul; 38(7-8):1140-64. PubMed ID: 18668443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A functional assay for quantitation of the apparent affinities of ligands of P-glycoprotein in Caco-2 cells.
    Gao J; Murase O; Schowen RL; Aubé J; Borchardt RT
    Pharm Res; 2001 Feb; 18(2):171-6. PubMed ID: 11405287
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Are MDCK cells transfected with the human MDR1 gene a good model of the human intestinal mucosa?
    Tang F; Horie K; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):765-72. PubMed ID: 12134945
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of P-glycoprotein mediated transport of K02, a novel vinylsulfone peptidomimetic cysteine protease inhibitor, across MDR1-MDCK and Caco-2 cell monolayers.
    Zhang Y; Benet LZ
    Pharm Res; 1998 Oct; 15(10):1520-4. PubMed ID: 9794492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic identification of membrane transporters that assist P-glycoprotein-mediated transport of digoxin and loperamide through a confluent monolayer of MDCKII-hMDR1 cells.
    Acharya P; O'Connor MP; Polli JW; Ayrton A; Ellens H; Bentz J
    Drug Metab Dispos; 2008 Feb; 36(2):452-60. PubMed ID: 17967933
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transport characteristics of peptidomimetics. Effect of the pyrrolinone bioisostere on transport across Caco-2 cell monolayers.
    Sudoh M; Pauletti GM; Yao W; Moser W; Yokoyama A; Pasternak A; Sprengeler PA; Smith AB; Hirschmann R; Borchardt RT
    Pharm Res; 1998 May; 15(5):719-25. PubMed ID: 9619780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.
    Rege BD; Kao JP; Polli JE
    Eur J Pharm Sci; 2002 Sep; 16(4-5):237-46. PubMed ID: 12208453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions.
    Neuhoff S; Ungell AL; Zamora I; Artursson P
    Pharm Res; 2003 Aug; 20(8):1141-8. PubMed ID: 12948010
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Many P-glycoprotein substrates do not inhibit the transport process across cell membranes.
    Barecki-Roach M; Wang EJ; Johnson WW
    Xenobiotica; 2003 Feb; 33(2):131-40. PubMed ID: 12623756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
    Zheng Y; Benet LZ; Okochi H; Chen X
    Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A biophysical model of passive and polarized active transport processes in Caco-2 cells: approaches to uncoupling apical and basolateral membrane events in the intact cell.
    Ho NF; Burton PS; Conradi RA; Barsuhn CL
    J Pharm Sci; 1995 Jan; 84(1):21-7. PubMed ID: 7714738
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
    Dahan A; Amidon GL
    Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of binding properties to human P-glycoprotein: development of a [3H]verapamil radioligand-binding assay.
    Döppenschmitt S; Langguth P; Regårdh CG; Andersson TB; Hilgendorf C; Spahn-Langguth H
    J Pharmacol Exp Ther; 1999 Jan; 288(1):348-57. PubMed ID: 9862789
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.